logo
Virtualware will uplist on Euronext Growth Paris on June 19, following market approval

Virtualware will uplist on Euronext Growth Paris on June 19, following market approval

Yahoo17-06-2025
– Virtualware (EPA:MLVIR), a pioneer in 3D-driven enterprise software, will uplist to Euronext Growth Paris on June 19 under the ticker ALVIR, following approval by the exchange's admission committee
Virtualware's uplist will enable the company to operate in a Multilateral Trading Facility with greater market liquidity, aiming for a broader diversification of its investor base and access to new financing instruments.
The company went public via a direct listing process on Euronext Access, the market's junior segment, in April 2023 at a valuation of 27 million euros.
"This process brings to culmination a two-year journey that began with listing on the Euronext Access Paris in April 2023 and marks an important step forward for Virtualware as we position ourselves to respond to the unprecedented rise in global demand for Real-time 3D enterprise solutions," said Unai Extremo, CEO, Virtualware.
"The uplisting will allow us to tap into increased liquidity and investor interest and fulfill our Strategic Plan, and open the doors to further, important markets," he added.
Recently, the company reported audited results showing a 91% increase in its full year 2024 EBITDA to 808,000 euros. Pre-tax profit climbed 1712% to 598,000 euros.
Financial net debt to EBITDA ratio stood at 0.5 times at the end of 2024. Subscription-based services accounted for 41% of total revenue. VIROO XRaaS revenue grew from 590,555 euros in 2022 to 1,288,060 euros in 2023, reaching 1,725,719 euros by the end of 2024 and marking a 192% increase over two years.
Euronext is a federation of exchanges comprising the Paris, Amsterdam, Brussels, Oslo, Milan, Lisbon, and Dublin markets. Meanwhile, Euronext Growth is the marketplace for high-potential SMEs seeking to access European capital. As a multilateral trading platform, it enables simultaneous trading across multiple European financial centers.
Virtualware, founded in 2004 and one of the leading experts in immersive and 3D technology solutions, has seen a 35% increase in the value of the company's shares since the initial listing in 2023. Virtualware's current market capitalization is € 36.79 million.
Virtualware's client base includes GE Vernova, Petronas, Volvo, Gestamp, Alstom, ADIF, Bosch, Biogen, Kessler Foundation, Invest WindsorEssex, McMaster University, the University of El Salvador, Ohio University, the Spanish Ministry of Defense and the Basque Government.
During this period, its software solutions have become synonymous with cutting-edge 3D enterprise.
In October 2024, Virtualware acquired Swedish company Simumatik, expanding its capabilities in digital twin and simulation technologies. This acquisition aligns with the company's three-year Strategic Plan to support key industries, including energy, automotive, transportation, defense, manufacturing, education, and healthcare.
In 2024, Virtualware also presented a three-year (2024-2026) Strategic Plan featuring expansion in North America, channel-based organic growth, and inorganic acquisitions.
The company's headquarters are in Bilbao, Spain, with offices in Orlando, US, Toronto, Canada, and Skövde, Sweden.
LKS Next acted as the transaction listing sponsor for the uplisting process. Kepler Cheuvreux will serve as liquidity provider once the company's shares start trading on Euronext Growth. Pedrosa acted as financial communications and investor relations advisor.
For further information:
Virtualwareir@virtualwareco.com
Safe HarborThis document is only provided for information purposes and does not constitute, nor should it be interpreted as, an offer to sell or exchange or acquire, or an invitation for offers to buy securities issued by any of the aforementioned companies. Any decision to buy or invest in securities in relation to a specific issue must be made solely and exclusively on the basis of the information set out in the pertinent prospectus filed by the company in relation to such specific issue. No one who becomes aware of the information contained in this report should regard it as definitive, because it is subject to changes and modifications.
This document contains or may contain forward looking statements regarding intentions, expectations or projections of Virtualware 2007, S.A. ('Virtualware' or the 'Company') or of its management on the date thereof, that refer to or incorporate various assumptions and projections, including projections about the future earnings of the business. The statements contained herein are based on our current projections, but the actual results may be substantially modified in the future by various risks and other factors that may cause the results or final decisions to differ from such intentions, projections or estimates. These factors include, without limitation, (1) the market situation, macroeconomic factors, regulatory, political or government guidelines, (2) domestic and international stock market movements, exchange rates and interest rates, (3) competitive pressures, (4) technological changes, (5) alterations in the financial situation, creditworthiness or solvency of our customers, debtors or counterparts. These factors could cause or result in actual events differing from the information and intentions stated, projected or forecast in this document or in other past or future documents. Virtualware does not undertake to publicly revise the contents of this or any other document, either if the events are not as described herein, or if such events lead to changes in the information contained in this document. This disclaimer needs to be taken into account by those persons which may take a decision over the base of this document or to elaborate or disseminate opinions based hereof. This document may contain summarised information or information that has not been audited. This document is confidential and it cannot be revealed or disclosed to third parties different from the original recipients, even partially, without Virtualware's prior consent.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Mistral in talks with VC firms, MGX to raise funds at $10 billion valuation, FT reports
Mistral in talks with VC firms, MGX to raise funds at $10 billion valuation, FT reports

Yahoo

time2 hours ago

  • Yahoo

Mistral in talks with VC firms, MGX to raise funds at $10 billion valuation, FT reports

(Reuters) -French artificial intelligence startup Mistral is in talks with investors, venture capital firms and Abu Dhabi's MGX to raise $1 billion at a valuation of $10 billion, the Financial Times reported on Friday, citing people familiar with the matter. The company launched in June Europe's first AI reasoning model, which uses logical thinking to create a response, as it tries to keep pace with American and Chinese rivals at the forefront of AI development. The funding would accelerate the commercial rollout of Mistral's Le Chat chatbot and support continued development of its large language models, the report said. MGX and Mistral did not immediately respond to Reuters requests for comment. The startup raised 600 million euros in a Series B funding round that valued the company at 5.8 billion euros last year. Industry observers consider Mistral as Europe's best-positioned AI company to rival Silicon Valley leaders, though the French firm has yet to achieve comparable market traction or revenue scale. Mistral counts Nvidia, Andreessen Horowitz and Lightspeed Venture Partners among its investors.

Tronox (TROX) Reports Q2 Loss, Lags Revenue Estimates
Tronox (TROX) Reports Q2 Loss, Lags Revenue Estimates

Yahoo

time2 hours ago

  • Yahoo

Tronox (TROX) Reports Q2 Loss, Lags Revenue Estimates

Tronox (TROX) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to earnings of $0.07 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -600.00%. A quarter ago, it was expected that this producer of titanium ore and titanium dioxide would post earnings of $0.02 per share when it actually produced a loss of $0.15, delivering a surprise of -850%. Over the last four quarters, the company has not been able to surpass consensus EPS estimates. Tronox, which belongs to the Zacks Chemical - Diversified industry, posted revenues of $731 million for the quarter ended June 2025, missing the Zacks Consensus Estimate by 5.98%. This compares to year-ago revenues of $820 million. The company has topped consensus revenue estimates just once over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Tronox shares have lost about 45.2% since the beginning of the year versus the S&P 500's gain of 8.3%. What's Next for Tronox? While Tronox has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Tronox was unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #4 (Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.12 on $779.62 million in revenues for the coming quarter and $0.04 on $3 billion in revenues for the current fiscal year. Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Chemical - Diversified is currently in the bottom 5% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. DuPont de Nemours (DD), another stock in the same industry, has yet to report results for the quarter ended June 2025. The results are expected to be released on August 5. This specialty chemicals maker is expected to post quarterly earnings of $1.06 per share in its upcoming report, which represents a year-over-year change of +9.3%. The consensus EPS estimate for the quarter has been revised 1.4% higher over the last 30 days to the current level. DuPont de Nemours' revenues are expected to be $3.22 billion, up 1.4% from the year-ago quarter. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Tronox Holdings PLC (TROX) : Free Stock Analysis Report DuPont de Nemours, Inc. (DD) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Clearbridge Health First Half 2025 Earnings: S$0.08 loss per share (vs S$0.004 loss in 1H 2024)
Clearbridge Health First Half 2025 Earnings: S$0.08 loss per share (vs S$0.004 loss in 1H 2024)

Yahoo

time2 hours ago

  • Yahoo

Clearbridge Health First Half 2025 Earnings: S$0.08 loss per share (vs S$0.004 loss in 1H 2024)

Clearbridge Health (Catalist:1H3) First Half 2025 Results Key Financial Results Revenue: S$4.92m (up 7.1% from 1H 2024). Net loss: S$1.35m (loss narrowed by 42% from 1H 2024). S$0.08 loss per share. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period Clearbridge Health shares are down 33% from a week ago. Risk Analysis Before you take the next step you should know about the 5 warning signs for Clearbridge Health (4 are potentially serious!) that we have uncovered. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store